TW0006472004
TW0006472004
BORA PHARMACEUTICALS CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 53.7B EUR | 53.72B EUR | 55.91B EUR | 61.97B EUR |
Enterprise Value | 69.33B EUR | 67.1B EUR | 68.63B EUR | 75.12B EUR |
Valuation Multiples | ||||
Trailing P/E | 29.61x | 34.72x | 34.77x | 39.17x |
Forward P/E | 12x | -- | -- | -- |
Price to Sales | 2.75x | 2.75x | 3.02x | 4.26x |
Price to Book | 3.54x | 3.55x | 3.84x | 4.03x |
EV/Revenue | 3.55x | 3.43x | 3.7x | 5.17x |
EV/EBITDA | 17.45x | 15.45x | 17.09x | 21.98x |
Price to FCF (P/FCF) | 34.24x | 27.37x | 20.92x | 27.42x |
EV/FCF | 44.2x | 34.19x | 25.68x | 33.24x |
FCF Yield | 2.92% | 3.65% | 4.78% | 3.65% |